BPRSJ338 exhibits high potency of anti-SARS-CoV-2 activity and is in development for fighting COVID-19 as a first-in-class drug. BPRSJ338 also potently inhibits against broad-spectrum coronaviruses including SARS-CoV-2, SARS-CoV, HCoV-229E, HCoV-OC43, TGEV, FIPV and MHV. Related US and Taiwan patents have been granted.​ Therefore it is also applicable to fight against severe evolving coronaviruses in the future.

An IOT sensor was presented to detect human motionvital signs with Wi-Fi signals. It mainly combines MIMO beamforming, injection-locking radarmachine learning techniques to recognizetrack physicalphysiological activities for health status monitoring. As a proof of concept for pandemic prevention, the presented sensor aims to inspect whether someone is exhibiting signssymptoms of COVID-19 infection within the Wi-Fi coverage area, such as fatigue, cough, shortness of breathirregular heart rhythm,even to detect sudden death.

A highly sensitivelinear ultrasonic radar was realized using digital self-injection-locking (SIL) technique. It can remotely monitor the vital signs of a human in motion, which will be demonstrated in this expo by upgrading a low-cost ultrasonic radar for reverse parking to support high-value telemedical applications. In the future it will further combine phased-array technology to implement non-contact 4D ultrasound system, which will bring disruptive innovation to medical technologies.